Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
64
AEHR Quote, Financials, Valuation and Earnings
Last price:
$14.73
Seasonality move
:
11.87%
Day range:
$13.67 - $14.70
52-week range:
$9.83 - $30.00
Dividend yield:
0%
P/E ratio:
14.34x
P/S ratio:
7.04x
P/B ratio:
3.40x
Volume:
820.8K
Avg. volume:
1.1M
1-year change:
-50.18%
Market cap:
$416.3M
Revenue:
$66.2M
EPS (TTM):
$1.12
Analysts' Opinion
-
Consensus RatingAehr Test Systems has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Aehr Test Systems has an estimated upside of 77.94% from its current price of $14.05.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $14.05.
Fair Value
-
According to the consensus of 0 analysts, Aehr Test Systems has 77.94% upside to fair value with a price target of -- per share.
AEHR vs. S&P 500
-
Over the past 5 trading days, Aehr Test Systems has underperformed the S&P 500 by -4.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Aehr Test Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aehr Test Systems revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Aehr Test Systems reported revenues of $16.6M.
Earnings Growth
-
Aehr Test Systems earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Aehr Test Systems reported earnings per share of $0.81.
Enterprise value:
378.5M
EV / Invested capital:
--
Price / LTM sales:
7.04x
EV / EBIT:
61.82x
EV / Revenue:
6.45x
PEG ratio (5yr expected):
0.27x
EV / Free cash flow:
-886.38x
Price / Operating cash flow:
413.27x
Enterprise value / EBITDA:
48.89x
Gross Profit (TTM):
$32.5M
Return On Assets:
31.03%
Net Income Margin (TTM):
50.07%
Return On Equity:
37.59%
Return On Invested Capital:
37.59%
Operating Margin:
15.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2023-08-31 | 2024-08-31 | |
| Income Statement | ||||||
| Revenue | $55.9M | $74.9M | $58.7M | $20.6M | $13.1M | |
| Gross Profit | $25.9M | $38.2M | $29.6M | $10M | $7.1M | |
| Operating Income | $9.3M | $17M | $6.1M | $4.1M | $159K | |
| EBITDA | $10.3M | $18.3M | $7.7M | $4.4M | $725K | |
| Diluted EPS | $0.33 | $0.64 | $0.98 | $0.16 | $0.02 | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $16M | $21.7M | $59.3M | $96.2M | $92.9M | |
| Total Assets | $18.7M | $24M | $61.6M | $105.5M | $145.9M | |
| Current Liabilities | $4.2M | $8.8M | $9.9M | $19.3M | $15.4M | |
| Total Liabilities | $6.4M | $9.8M | $10.1M | $25.3M | $23.4M | |
| Total Equity | $12.3M | $14.2M | $51.5M | $80.1M | $122.5M | |
| Total Debt | $1.7M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2023-08-31 | 2024-08-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.1M | $8.5M | $235K | $3.9M | $2.4M | |
| Cash From Investing | -$441K | -$856K | -$11.3M | $17.7M | -$10.8M | |
| Cash From Financing | $24.9M | $7.4M | $727K | -$694K | -$106K | |
| Free Cash Flow | $4.7M | $6.9M | -$427K | $3.6M | $2.2M | |
AEHR
Sector
Market Cap
$416.3M
$123.6M
Price % of 52-Week High
46.83%
67.76%
Dividend Yield
0%
0%
Shareholder Yield
0.02%
1%
1-Year Price Total Return
-50.18%
-7.22%
Beta (5-Year)
1.940
0.944
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$13.43
200-day SMA
Buy
Level
$13.15
Bollinger Bands (100)
Buy
Level
11.89 - 14.71
Chaikin Money Flow
Buy
Level
93.7M
20-day SMA
Buy
Level
$12.59
Relative Strength Index (RSI14)
Buy
Level
58.36
ADX Line
Sell
Level
16.81
Williams %R
Neutral
Level
-35.5161
50-day SMA
Buy
Level
$13.12
MACD (12, 26)
Buy
Level
0.39
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
346.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.6578)
Buy
CA Score
(Annual)
Level (1.6729)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-4.2443)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
Stock Forecast FAQ
In the current month, AEHR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AEHR average analyst price target in the past 3 months is --.
-
Where Will Aehr Test Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aehr Test Systems share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Aehr Test Systems?
Analysts are divided on their view about Aehr Test Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aehr Test Systems is a Sell and believe this share price will drop from its current level to --.
-
What Is Aehr Test Systems's Price Target?
The price target for Aehr Test Systems over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AEHR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aehr Test Systems is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AEHR?
You can purchase shares of Aehr Test Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aehr Test Systems shares.
-
What Is The Aehr Test Systems Share Price Today?
Aehr Test Systems was last trading at $14.73 per share. This represents the most recent stock quote for Aehr Test Systems. Yesterday, Aehr Test Systems closed at $14.05 per share.
-
How To Buy Aehr Test Systems Stock Online?
In order to purchase Aehr Test Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.05% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.62% over the past day.
